LOCUS       GCR_MOUSE                792 aa            linear   ROD 29-MAY-2024
DEFINITION  RecName: Full=Glucocorticoid receptor; Short=GR; AltName:
            Full=Nuclear receptor subfamily 3 group C member 1.
ACCESSION   P06537
VERSION     P06537.2
DBSOURCE    UniProtKB: locus GCR_MOUSE, accession P06537;
            class: standard.
            extra
            accessions:E0ZPU5,E9PUR6,E9PYV1,Q06VW2,Q3U126,Q3U2M7,Q61628,Q61629
            created: Jan 1, 1988.
            sequence updated: Sep 29, 2021.
            annotation updated: May 29, 2024.
            xrefs: X04435.1, CAA28031.1, DQ504162.1, ABF57998.1, HM236293.1,
            ADM18962.1, AK155200.1, BAE33113.1, AK156323.1, BAE33674.1,
            GL456180.3, BC129912.1, AAI29913.1, BC129913.1, AAI29914.1,
            X13358.1, CAA31738.1, X13359.1, CAA31739.1, A25691, NP_032199.3,
            XP_006525721.1, XP_006525722.1, XP_006525723.1, XP_006525724.1,
            XP_006525725.1, XP_006525726.1, XP_006525727.1, XP_006525728.1,
            XP_006525729.1, XP_017173324.1, XP_017173325.1, XP_017173326.1,
            XP_017173327.1, 3MNE_A, 3MNO_A, 3MNP_A
            xrefs (non-sequence databases): CCDS:CCDS37791.1, PDBsum:3MNE,
            PDBsum:3MNO, PDBsum:3MNP, AlphaFoldDB:P06537, SMR:P06537,
            CORUM:P06537, DIP:DIP-11N, IntAct:P06537, MINT:P06537,
            STRING:10090.ENSMUSP00000111229, BindingDB:P06537,
            ChEMBL:CHEMBL3144, DrugCentral:P06537, GuidetoPHARMACOLOGY:625,
            GlyGen:P06537, iPTMnet:P06537, PhosphoSitePlus:P06537,
            SwissPalm:P06537, EPD:P06537, jPOST:P06537, MaxQB:P06537,
            PaxDb:10090-ENSMUSP00000095199, PeptideAtlas:P06537,
            ProteomicsDB:271197, ProteomicsDB:271198, ProteomicsDB:271199,
            ProteomicsDB:271200, ProteomicsDB:271201, ProteomicsDB:333325,
            ProteomicsDB:355014, Pumba:P06537, Antibodypedia:1329, DNASU:14815,
            Ensembl:ENSMUST00000025300.13, Ensembl:ENSMUSP00000025300.7,
            Ensembl:ENSMUSG00000024431.16, Ensembl:ENSMUST00000097592.9,
            Ensembl:ENSMUSP00000095199.3, Ensembl:ENSMUST00000115567.8,
            Ensembl:ENSMUSP00000111229.2, Ensembl:ENSMUST00000115571.8,
            Ensembl:ENSMUSP00000111233.2, GeneID:14815, KEGG:mmu:14815,
            UCSC:uc008esx.1, AGR:MGI:95824, CTD:2908, MGI:95824,
            VEuPathDB:HostDB:ENSMUSG00000024431, eggNOG:KOG3575,
            GeneTree:ENSGT00940000156385, HOGENOM:CLU_020317_0_0_1,
            InParanoid:P06537, OMA:GLYMGDT, OrthoDB:5305911at2759,
            TreeFam:TF106510, Reactome:R-MMU-3371497, Reactome:R-MMU-383280,
            Reactome:R-MMU-4090294, BioGRID-ORCS:14815, ChiTaRS:Nr3c1,
            EvolutionaryTrace:P06537, PRO:PR:P06537, Proteomes:UP000000589,
            RNAct:P06537, Bgee:ENSMUSG00000024431, GO:0005813, GO:0005737,
            GO:0005829, GO:0043197, GO:0098978, GO:0016020, GO:0005739,
            GO:0016607, GO:0005654, GO:0005634, GO:0099092, GO:0032991,
            GO:0005819, GO:0003682, GO:0001046, GO:0003677, GO:0001228,
            GO:0003700, GO:0001227, GO:0003690, GO:0034056, GO:0031072,
            GO:0042562, GO:0030544, GO:0051879, GO:0042802, GO:0004883,
            GO:0004879, GO:0019901, GO:0044877, GO:0030971, GO:0000977,
            GO:0043565, GO:0005496, GO:1990239, GO:0017025, GO:0003713,
            GO:0008270, GO:0030325, GO:0048708, GO:0071549, GO:0071560,
            GO:0006338, GO:0010467, GO:0008211, GO:0042921, GO:0030518,
            GO:0060603, GO:0042711, GO:0014004, GO:0061744, GO:0043066,
            GO:0031914, GO:0043116, GO:0150076, GO:0061051, GO:0060999,
            GO:2000324, GO:0014049, GO:1902895, GO:0043525, GO:0045944,
            GO:0042127, GO:0006355, GO:0031946, GO:0006111, GO:0010906,
            GO:0006357, GO:0046685, GO:0035249, GO:0045815, CDD:cd07172,
            CDD:cd07076, Gene3D:3.30.50.10, Gene3D:1.10.565.10,
            InterPro:IPR001409, InterPro:IPR035500, InterPro:IPR000536,
            InterPro:IPR001723, InterPro:IPR001628, InterPro:IPR013088,
            PANTHER:PTHR48092:SF5, PANTHER:PTHR48092, Pfam:PF02155,
            Pfam:PF00104, Pfam:PF00105, PRINTS:PR00528, PRINTS:PR00398,
            PRINTS:PR00047, SMART:SM00430, SMART:SM00399, SUPFAM:SSF57716,
            SUPFAM:SSF48508, PROSITE:PS51843, PROSITE:PS00031, PROSITE:PS51030
KEYWORDS    3D-structure; Acetylation; Alternative initiation; Alternative
            splicing; Chromatin regulator; Cytoplasm; Cytoskeleton;
            DNA-binding; Isopeptide bond; Lipid-binding; Metal-binding;
            Methylation; Mitochondrion; Nucleus; Phosphoprotein; Receptor;
            Reference proteome; Steroid-binding; Transcription; Transcription
            regulation; Ubl conjugation; Zinc; Zinc-finger.
SOURCE      Mus musculus (house mouse)
  ORGANISM  Mus musculus
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
            Muroidea; Muridae; Murinae; Mus; Mus.
REFERENCE   1  (residues 1 to 792)
  AUTHORS   Danielsen,M., Northrop,J.P. and Ringold,G.M.
  TITLE     The mouse glucocorticoid receptor: mapping of functional domains by
            cloning, sequencing and expression of wild-type and mutant receptor
            proteins
  JOURNAL   EMBO J 5 (10), 2513-2522 (1986)
   PUBMED   3780669
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT 78-GLN--GLN-86
            DEL.
REFERENCE   2  (residues 1 to 792)
  AUTHORS   Xu,D., Buehner,A., Xu,J., Lambert,T., Nekl,C., Nielsen,M.K. and
            Zhou,Y.
  TITLE     A polymorphic glucocorticoid receptor in a mouse population may
            explain inherited altered stress response and increased
            anxiety-type behaviors
  JOURNAL   FASEB J 20 (13), 2414-2416 (2006)
   PUBMED   17012242
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT GLN-91 DEL, AND
            POLYMORPHISM.
REFERENCE   3  (residues 1 to 792)
  AUTHORS   Hinds,T.D. Jr., Ramakrishnan,S., Cash,H.A., Stechschulte,L.A.,
            Heinrich,G., Najjar,S.M. and Sanchez,E.R.
  TITLE     Discovery of glucocorticoid receptor-beta in mice with a role in
            metabolism
  JOURNAL   Mol Endocrinol 24 (9), 1715-1727 (2010)
   PUBMED   20660300
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, SUBCELLULAR
            LOCATION, TISSUE SPECIFICITY, INDUCTION, AND VARIANT 78-GLN--GLN-86
            DEL.
REFERENCE   4  (residues 1 to 792)
  AUTHORS   Carninci,P., Kasukawa,T., Katayama,S., Gough,J., Frith,M.C.,
            Maeda,N., Oyama,R., Ravasi,T., Lenhard,B., Wells,C., Kodzius,R.,
            Shimokawa,K., Bajic,V.B., Brenner,S.E., Batalov,S., Forrest,A.R.,
            Zavolan,M., Davis,M.J., Wilming,L.G., Aidinis,V., Allen,J.E.,
            Ambesi-Impiombato,A., Apweiler,R., Aturaliya,R.N., Bailey,T.L.,
            Bansal,M., Baxter,L., Beisel,K.W., Bersano,T., Bono,H., Chalk,A.M.,
            Chiu,K.P., Choudhary,V., Christoffels,A., Clutterbuck,D.R.,
            Crowe,M.L., Dalla,E., Dalrymple,B.P., de Bono,B., Della Gatta,G.,
            di Bernardo,D., Down,T., Engstrom,P., Fagiolini,M., Faulkner,G.,
            Fletcher,C.F., Fukushima,T., Furuno,M., Futaki,S., Gariboldi,M.,
            Georgii-Hemming,P., Gingeras,T.R., Gojobori,T., Green,R.E.,
            Gustincich,S., Harbers,M., Hayashi,Y., Hensch,T.K., Hirokawa,N.,
            Hill,D., Huminiecki,L., Iacono,M., Ikeo,K., Iwama,A., Ishikawa,T.,
            Jakt,M., Kanapin,A., Katoh,M., Kawasawa,Y., Kelso,J., Kitamura,H.,
            Kitano,H., Kollias,G., Krishnan,S.P., Kruger,A., Kummerfeld,S.K.,
            Kurochkin,I.V., Lareau,L.F., Lazarevic,D., Lipovich,L., Liu,J.,
            Liuni,S., McWilliam,S., Madan Babu,M., Madera,M., Marchionni,L.,
            Matsuda,H., Matsuzawa,S., Miki,H., Mignone,F., Miyake,S.,
            Morris,K., Mottagui-Tabar,S., Mulder,N., Nakano,N., Nakauchi,H.,
            Ng,P., Nilsson,R., Nishiguchi,S., Nishikawa,S., Nori,F., Ohara,O.,
            Okazaki,Y., Orlando,V., Pang,K.C., Pavan,W.J., Pavesi,G.,
            Pesole,G., Petrovsky,N., Piazza,S., Reed,J., Reid,J.F., Ring,B.Z.,
            Ringwald,M., Rost,B., Ruan,Y., Salzberg,S.L., Sandelin,A.,
            Schneider,C., Schonbach,C., Sekiguchi,K., Semple,C.A., Seno,S.,
            Sessa,L., Sheng,Y., Shibata,Y., Shimada,H., Shimada,K., Silva,D.,
            Sinclair,B., Sperling,S., Stupka,E., Sugiura,K., Sultana,R.,
            Takenaka,Y., Taki,K., Tammoja,K., Tan,S.L., Tang,S., Taylor,M.S.,
            Tegner,J., Teichmann,S.A., Ueda,H.R., van Nimwegen,E., Verardo,R.,
            Wei,C.L., Yagi,K., Yamanishi,H., Zabarovsky,E., Zhu,S., Zimmer,A.,
            Hide,W., Bult,C., Grimmond,S.M., Teasdale,R.D., Liu,E.T.,
            Brusic,V., Quackenbush,J., Wahlestedt,C., Mattick,J.S., Hume,D.A.,
            Kai,C., Sasaki,D., Tomaru,Y., Fukuda,S., Kanamori-Katayama,M.,
            Suzuki,M., Aoki,J., Arakawa,T., Iida,J., Imamura,K., Itoh,M.,
            Kato,T., Kawaji,H., Kawagashira,N., Kawashima,T., Kojima,M.,
            Kondo,S., Konno,H., Nakano,K., Ninomiya,N., Nishio,T., Okada,M.,
            Plessy,C., Shibata,K., Shiraki,T., Suzuki,S., Tagami,M., Waki,K.,
            Watahiki,A., Okamura-Oho,Y., Suzuki,H., Kawai,J. and Hayashizaki,Y.
  CONSRTM   FANTOM Consortium; RIKEN Genome Exploration Research Group and
            Genome Science Group (Genome Network Project Core Group)
  TITLE     The transcriptional landscape of the mammalian genome
  JOURNAL   Science 309 (5740), 1559-1563 (2005)
   PUBMED   16141072
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
            78-GLN--GLN-86 DEL.;
            STRAIN=NOD
            Erratum:[Science. 2006 Mar 24;311(5768):1713]
REFERENCE   5  (residues 1 to 792)
  AUTHORS   Church,D.M., Goodstadt,L., Hillier,L.W., Zody,M.C., Goldstein,S.,
            She,X., Bult,C.J., Agarwala,R., Cherry,J.L., DiCuccio,M.,
            Hlavina,W., Kapustin,Y., Meric,P., Maglott,D., Birtle,Z.,
            Marques,A.C., Graves,T., Zhou,S., Teague,B., Potamousis,K.,
            Churas,C., Place,M., Herschleb,J., Runnheim,R., Forrest,D.,
            Amos-Landgraf,J., Schwartz,D.C., Cheng,Z., Lindblad-Toh,K.,
            Eichler,E.E. and Ponting,C.P.
  CONSRTM   Mouse Genome Sequencing Consortium
  TITLE     Lineage-specific biology revealed by a finished genome assembly of
            the mouse
  JOURNAL   PLoS Biol 7 (5), e1000112 (2009)
   PUBMED   19468303
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].;
            STRAIN=C57BL/6J
REFERENCE   6  (residues 1 to 792)
  AUTHORS   Gerhard,D.S., Wagner,L., Feingold,E.A., Shenmen,C.M., Grouse,L.H.,
            Schuler,G., Klein,S.L., Old,S., Rasooly,R., Good,P., Guyer,M.,
            Peck,A.M., Derge,J.G., Lipman,D., Collins,F.S., Jang,W., Sherry,S.,
            Feolo,M., Misquitta,L., Lee,E., Rotmistrovsky,K., Greenhut,S.F.,
            Schaefer,C.F., Buetow,K., Bonner,T.I., Haussler,D., Kent,J.,
            Kiekhaus,M., Furey,T., Brent,M., Prange,C., Schreiber,K.,
            Shapiro,N., Bhat,N.K., Hopkins,R.F., Hsie,F., Driscoll,T.,
            Soares,M.B., Casavant,T.L., Scheetz,T.E., Brown-stein,M.J.,
            Usdin,T.B., Toshiyuki,S., Carninci,P., Piao,Y., Dudekula,D.B.,
            Ko,M.S., Kawakami,K., Suzuki,Y., Sugano,S., Gruber,C.E.,
            Smith,M.R., Simmons,B., Moore,T., Waterman,R., Johnson,S.L.,
            Ruan,Y., Wei,C.L., Mathavan,S., Gunaratne,P.H., Wu,J., Garcia,A.M.,
            Hulyk,S.W., Fuh,E., Yuan,Y., Sneed,A., Kowis,C., Hodgson,A.,
            Muzny,D.M., McPherson,J., Gibbs,R.A., Fahey,J., Helton,E.,
            Ketteman,M., Madan,A., Rodrigues,S., Sanchez,A., Whiting,M.,
            Madari,A., Young,A.C., Wetherby,K.D., Granite,S.J., Kwong,P.N.,
            Brinkley,C.P., Pearson,R.L., Bouffard,G.G., Blakesly,R.W.,
            Green,E.D., Dickson,M.C., Rodriguez,A.C., Grimwood,J., Schmutz,J.,
            Myers,R.M., Butterfield,Y.S., Griffith,M., Griffith,O.L.,
            Krzywinski,M.I., Liao,N., Morin,R., Palmquist,D., Petrescu,A.S.,
            Skalska,U., Smailus,D.E., Stott,J.M., Schnerch,A., Schein,J.E.,
            Jones,S.J., Holt,R.A., Baross,A., Marra,M.A., Clifton,S.,
            Makowski,K.A., Bosak,S. and Malek,J.
  CONSRTM   MGC Project Team
  TITLE     The status, quality, and expansion of the NIH full-length cDNA
            project: the Mammalian Gene Collection (MGC)
  JOURNAL   Genome Res 14 (10B), 2121-2127 (2004)
   PUBMED   15489334
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
            78-GLN--GLN-86 DEL.
            Erratum:[Genome Res. 2006 Jun;16(6):804. Morrin, Ryan [corrected to
            Morin, Ryan]]
REFERENCE   7  (residues 1 to 792)
  AUTHORS   Nohno,T., Kasai,Y. and Saito,T.
  TITLE     Novel cDNA sequence possibly generated by alternative splicing of a
            mouse glucocorticoid receptor gene transcript from Shionogi
            carcinoma 115
  JOURNAL   Nucleic Acids Res 17 (1), 445 (1989)
   PUBMED   2911477
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 1-764 (ISOFORMS 1 AND 2).
REFERENCE   8  (residues 1 to 792)
  AUTHORS   Vedeckis,W.V., Ali,M. and Allen,H.R.
  TITLE     Regulation of glucocorticoid receptor protein and mRNA levels
  JOURNAL   Cancer Res 49 (8 Suppl), 2295s-2302s (1989)
   PUBMED   2702670
  REMARK    GLUCOCORTICOID-MEDIATED DOWN-REGULATION.
REFERENCE   9  (residues 1 to 792)
  AUTHORS   Bodwell,J.E., Orti,E., Coull,J.M., Pappin,D.J., Smith,L.I. and
            Swift,F.
  TITLE     Identification of phosphorylated sites in the mouse glucocorticoid
            receptor
  JOURNAL   J Biol Chem 266 (12), 7549-7555 (1991)
   PUBMED   2019585
  REMARK    PHOSPHORYLATION AT SER-131; SER-159; THR-168; SER-221; SER-229;
            SER-243 AND SER-324.
REFERENCE   10 (residues 1 to 792)
  AUTHORS   Silverstein,A.M., Galigniana,M.D., Chen,M.S., Owens-Grillo,J.K.,
            Chinkers,M. and Pratt,W.B.
  TITLE     Protein phosphatase 5 is a major component of glucocorticoid
            receptor.hsp90 complexes with properties of an FK506-binding
            immunophilin
  JOURNAL   J Biol Chem 272 (26), 16224-16230 (1997)
   PUBMED   9195923
  REMARK    IDENTIFICATION IN A COMPLEX WITH NR3C1 AND FKBP4; PPID; PPP5C OR
            STIP1.
REFERENCE   11 (residues 1 to 792)
  AUTHORS   Cella,N., Groner,B. and Hynes,N.E.
  TITLE     Characterization of Stat5a and Stat5b homodimers and heterodimers
            and their association with the glucocortiocoid receptor in mammary
            cells
  JOURNAL   Mol Cell Biol 18 (4), 1783-1792 (1998)
   PUBMED   9528750
  REMARK    INTERACTION WITH STAT5A AND STAT5B.
REFERENCE   12 (residues 1 to 792)
  AUTHORS   Chang,C.J., Chen,Y.L. and Lee,S.C.
  TITLE     Coactivator TIF1beta interacts with transcription factor C/EBPbeta
            and glucocorticoid receptor to induce alpha1-acid glycoprotein gene
            expression
  JOURNAL   Mol Cell Biol 18 (10), 5880-5887 (1998)
   PUBMED   9742105
  REMARK    INTERACTION WITH TRIM28.
REFERENCE   13 (residues 1 to 792)
  AUTHORS   Yang,L., Guerrero,J., Hong,H., DeFranco,D.B. and Stallcup,M.R.
  TITLE     Interaction of the tau2 transcriptional activation domain of
            glucocorticoid receptor with a novel steroid receptor coactivator,
            Hic-5, which localizes to both focal adhesions and the nuclear
            matrix
  JOURNAL   Mol Biol Cell 11 (6), 2007-2018 (2000)
   PUBMED   10848625
  REMARK    INTERACTION WITH TGFB1I1.
REFERENCE   14 (residues 1 to 792)
  AUTHORS   McNally,J.G., Muller,W.G., Walker,D., Wolford,R. and Hager,G.L.
  TITLE     The glucocorticoid receptor: rapid exchange with regulatory sites
            in living cells
  JOURNAL   Science 287 (5456), 1262-1265 (2000)
   PUBMED   10678832
  REMARK    FUNCTION, AND SUBCELLULAR LOCATION.
REFERENCE   15 (residues 1 to 792)
  AUTHORS   Galigniana,M.D., Radanyi,C., Renoir,J.M., Housley,P.R. and
            Pratt,W.B.
  TITLE     Evidence that the peptidylprolyl isomerase domain of the
            hsp90-binding immunophilin FKBP52 is involved in both dynein
            interaction and glucocorticoid receptor movement to the nucleus
  JOURNAL   J Biol Chem 276 (18), 14884-14889 (2001)
   PUBMED   11278753
  REMARK    SUBCELLULAR LOCATION, HETEROMULTIMERIC COMPLEX FORMATION,
            INTERACTION WITH FKBP4, AND MECHANISM OF TRANSLOCATION TO THE
            NUCLEUS.
REFERENCE   16 (residues 1 to 792)
  AUTHORS   Wallace,A.D. and Cidlowski,J.A.
  TITLE     Proteasome-mediated glucocorticoid receptor degradation restricts
            transcriptional signaling by glucocorticoids
  JOURNAL   J Biol Chem 276 (46), 42714-42721 (2001)
   PUBMED   11555652
  REMARK    UBIQUITINATION AT LYS-435, MUTAGENESIS OF LYS-435, AND
            GLUCOCORTICOID-MEDIATED DOWN-REGULATION.
REFERENCE   17 (residues 1 to 792)
  AUTHORS   Yudt,M.R. and Cidlowski,J.A.
  TITLE     Molecular identification and characterization of a and b forms of
            the glucocorticoid receptor
  JOURNAL   Mol Endocrinol 15 (7), 1093-1103 (2001)
   PUBMED   11435610
  REMARK    ALTERNATIVE INITIATION, AND MUTAGENESIS OF MET-1 AND MET-28.
REFERENCE   18 (residues 1 to 792)
  AUTHORS   Davies,T.H., Ning,Y.M. and Sanchez,E.R.
  TITLE     A new first step in activation of steroid receptors:
            hormone-induced switching of FKBP51 and FKBP52 immunophilins
  JOURNAL   J Biol Chem 277 (7), 4597-4600 (2002)
   PUBMED   11751894
  REMARK    HETEROMULTIMERIC COMPLEX FORMATION, AND MECHANISM OF TRANSLOCATION
            TO THE NUCLEUS.
REFERENCE   19 (residues 1 to 792)
  AUTHORS   Brewer,J.A., Khor,B., Vogt,S.K., Muglia,L.M., Fujiwara,H.,
            Haegele,K.E., Sleckman,B.P. and Muglia,L.J.
  TITLE     T-cell glucocorticoid receptor is required to suppress
            COX-2-mediated lethal immune activation
  JOURNAL   Nat Med 9 (10), 1318-1322 (2003)
   PUBMED   12949501
  REMARK    INVOLVEMENT IN IMMUNE SYSTEM DEVELOPMENT.
REFERENCE   20 (residues 1 to 792)
  AUTHORS   Tronche,F., Opherk,C., Moriggl,R., Kellendonk,C., Reimann,A.,
            Schwake,L., Reichardt,H.M., Stangl,K., Gau,D., Hoeflich,A.,
            Beug,H., Schmid,W. and Schutz,G.
  TITLE     Glucocorticoid receptor function in hepatocytes is essential to
            promote postnatal body growth
  JOURNAL   Genes Dev 18 (5), 492-497 (2004)
   PUBMED   15037546
  REMARK    POSSIBLE FUNCTION IN THE CONTROL OF BODY GROWTH.
REFERENCE   21 (residues 1 to 792)
  AUTHORS   Huttlin,E.L., Jedrychowski,M.P., Elias,J.E., Goswami,T., Rad,R.,
            Beausoleil,S.A., Villen,J., Haas,W., Sowa,M.E. and Gygi,S.P.
  TITLE     A tissue-specific atlas of mouse protein phosphorylation and
            expression
  JOURNAL   Cell 143 (7), 1174-1189 (2010)
   PUBMED   21183079
  REMARK    PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421, AND
            IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].;
            TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, and
            Pancreas
REFERENCE   22 (residues 1 to 792)
  AUTHORS   Hinds,T.D. Jr., Stechschulte,L.A., Cash,H.A., Whisler,D.,
            Banerjee,A., Yong,W., Khuder,S.S., Kaw,M.K., Shou,W., Najjar,S.M.
            and Sanchez,E.R.
  TITLE     Protein phosphatase 5 mediates lipid metabolism through reciprocal
            control of glucocorticoid receptor and peroxisome
            proliferator-activated receptor-gamma (PPARgamma)
  JOURNAL   J Biol Chem 286 (50), 42911-42922 (2011)
   PUBMED   21994940
  REMARK    FUNCTION IN ADIPOGENESIS, INTERACTION WITH FKBP5 AND PPP5C,
            PHOSPHORYLATION AT SER-221; SER-229 AND SER-243, AND
            DEPHOSPHORYLATION AT SER-221 AND SER-243 BY PPP5C.
REFERENCE   23 (residues 1 to 792)
  AUTHORS   Lamia,K.A., Papp,S.J., Yu,R.T., Barish,G.D., Uhlenhaut,N.H.,
            Jonker,J.W., Downes,M. and Evans,R.M.
  TITLE     Cryptochromes mediate rhythmic repression of the glucocorticoid
            receptor
  JOURNAL   Nature 480 (7378), 552-556 (2011)
   PUBMED   22170608
  REMARK    INTERACTION WITH CRY1 AND CRY2.
            Publication Status: Online-Only
REFERENCE   24 (residues 1 to 792)
  AUTHORS   Guo,A., Gu,H., Zhou,J., Mulhern,D., Wang,Y., Lee,K.A., Yang,V.,
            Aguiar,M., Kornhauser,J., Jia,X., Ren,J., Beausoleil,S.A.,
            Silva,J.C., Vemulapalli,V., Bedford,M.T. and Comb,M.J.
  TITLE     Immunoaffinity enrichment and mass spectrometry analysis of protein
            methylation
  JOURNAL   Mol Cell Proteomics 13 (1), 372-387 (2014)
   PUBMED   24129315
  REMARK    METHYLATION [LARGE SCALE ANALYSIS] AT ARG-24, AND IDENTIFICATION BY
            MASS SPECTROMETRY [LARGE SCALE ANALYSIS].;
            TISSUE=Brain, and Embryo
REFERENCE   25 (residues 1 to 792)
  AUTHORS   Goriki,A., Hatanaka,F., Myung,J., Kim,J.K., Yoritaka,T., Tanoue,S.,
            Abe,T., Kiyonari,H., Fujimoto,K., Kato,Y., Todo,T., Matsubara,A.,
            Forger,D. and Takumi,T.
  TITLE     A novel protein, CHRONO, functions as a core component of the
            mammalian circadian clock
  JOURNAL   PLoS Biol 12 (4), e1001839 (2014)
   PUBMED   24736997
  REMARK    INTERACTION WITH CIART.
            Publication Status: Online-Only
REFERENCE   26 (residues 1 to 792)
  AUTHORS   Matthews,L.C., Berry,A.A., Morgan,D.J., Poolman,T.M., Bauer,K.,
            Kramer,F., Spiller,D.G., Richardson,R.V., Chapman,K.E.,
            Farrow,S.N., Norman,M.R., Williamson,A.J., Whetton,A.D.,
            Taylor,S.S., Tuckermann,J.P., White,M.R. and Ray,D.W.
  TITLE     Glucocorticoid receptor regulates accurate chromosome segregation
            and is associated with malignancy
  JOURNAL   Proc Natl Acad Sci U S A 112 (17), 5479-5484 (2015)
   PUBMED   25847991
  REMARK    FUNCTION.
REFERENCE   27 (residues 1 to 792)
  AUTHORS   Banuelos,J., Shin,S.C. and Lu,N.Z.
  TITLE     A hotspot in the glucocorticoid receptor DNA-binding domain
            susceptible to loss of function mutation
  JOURNAL   Steroids 96, 115-120 (2015)
   PUBMED   25676786
  REMARK    SUBCELLULAR LOCATION, AND MUTAGENESIS OF ARG-493.
REFERENCE   28 (residues 1 to 792)
  AUTHORS   Kriebs,A., Jordan,S.D., Soto,E., Henriksson,E., Sandate,C.R.,
            Vaughan,M.E., Chan,A.B., Duglan,D., Papp,S.J., Huber,A.L.,
            Afetian,M.E., Yu,R.T., Zhao,X., Downes,M., Evans,R.M. and
            Lamia,K.A.
  TITLE     Circadian repressors CRY1 and CRY2 broadly interact with nuclear
            receptors and modulate transcriptional activity
  JOURNAL   Proc Natl Acad Sci U S A 114 (33), 8776-8781 (2017)
   PUBMED   28751364
  REMARK    INTERACTION WITH CRY1 AND CRY2.
REFERENCE   29 (residues 1 to 792)
  AUTHORS   Okabe,T., Chavan,R., Fonseca Costa,S.S., Brenna,A., Ripperger,J.A.
            and Albrecht,U.
  TITLE     REV-ERBalpha influences the stability and nuclear localization of
            the glucocorticoid receptor
  JOURNAL   J Cell Sci 129 (21), 4143-4154 (2016)
   PUBMED   27686098
  REMARK    INTERACTION WITH HSP90AA1 AND HSP90AB1, SUBCELLULAR LOCATION, AND
            TISSUE SPECIFICITY.
COMMENT     On or before Nov 19, 2021 this sequence version replaced
            gi:123789244, gi:123794017, gi:123794105, P06537.1.
            [FUNCTION] Receptor for glucocorticoids (GC). Has a dual mode of
            action: as a transcription factor that binds to glucocorticoid
            response elements (GRE), both for nuclear and mitochondrial DNA,
            and as a modulator of other transcription factors. Affects
            inflammatory responses, cellular proliferation and differentiation
            in target tissues. Involved in chromatin remodeling
            (PubMed:10678832). Plays a role in rapid mRNA degradation by
            binding to the 5' UTR of target mRNAs and interacting with PNRC2 in
            a ligand-dependent manner which recruits the RNA helicase UPF1 and
            the mRNA-decapping enzyme DCP1A, leading to RNA decay (By
            similarity). Could act as a coactivator for STAT5-dependent
            transcription upon growth hormone (GH) stimulation and could reveal
            an essential role of hepatic GR in the control of body growth
            (PubMed:15037546). {ECO:0000250|UniProtKB:P04150,
            ECO:0000269|PubMed:10678832, ECO:0000269|PubMed:15037546}.
            [FUNCTION] [Isoform 1]: Has transcriptional activation and
            repression activity (By similarity). Mediates
            glucocorticoid-induced apoptosis (By similarity). Promotes accurate
            chromosome segregation during mitosis (PubMed:25847991). May act as
            a tumor suppressor (PubMed:25847991). May play a negative role in
            adipogenesis through the regulation of lipolytic and antilipogenic
            gene expression (PubMed:21994940). {ECO:0000250|UniProtKB:P04150,
            ECO:0000269|PubMed:21994940, ECO:0000269|PubMed:25847991}.
            [FUNCTION] [Isoform 3]: Acts as a dominant negative inhibitor of
            isoform 1 (PubMed:20660300). Has intrinsic transcriptional activity
            independent of isoform Alpha when both isoforms are coexpressed (By
            similarity). Loses this transcription modulator function on its own
            (By similarity). Has no hormone-binding activity (PubMed:20660300).
            May play a role in controlling glucose metabolism by maintaining
            insulin sensitivity (PubMed:20660300). Reduces hepatic
            gluconeogenesis through down-regulation of PEPCK in an isoform
            Alpha-dependent manner (By similarity). Directly regulates STAT1
            expression in isoform Alpha-independent manner (By similarity).
            {ECO:0000250|UniProtKB:P04150, ECO:0000269|PubMed:20660300}.
            [SUBUNIT] Heteromultimeric cytoplasmic complex with HSP90AA1,
            HSPA1A/HSPA1B, and FKBP5 or another immunophilin such as PPID,
            STIP1, or the immunophilin homolog PPP5C (PubMed:21994940,
            PubMed:9195923). Upon ligand binding FKBP5 dissociates from the
            complex and FKBP4 takes its place, thereby linking the complex to
            dynein and mediating transport to the nucleus, where the complex
            dissociates (PubMed:11278753, PubMed:9195923). Probably forms a
            complex composed of chaperones HSP90 and HSP70, co-chaperones
            CDC37, PPP5C, TSC1 and client protein TSC2, CDK4, AKT, RAF1 and
            NR3C1; this complex does not contain co-chaperones STIP1/HOP and
            PTGES3/p23 (By similarity). Directly interacts with UNC45A (By
            similarity). Binds to DNA as a homodimer, and as heterodimer with
            NR3C2 or the retinoid X receptor. Binds STAT5A and STAT5B
            homodimers and heterodimers (PubMed:9528750). Interacts with NRIP1,
            POU2F1, POU2F2 and TRIM28 (PubMed:9742105). Interacts with several
            coactivator complexes, including the SMARCA4 complex, CREBBP/EP300,
            TADA2L (Ada complex) and p160 coactivators such as NCOA2 and NCOA6
            (By similarity). Interaction with BAG1 inhibits transactivation (By
            similarity). Interacts with HEXIM1 and TGFB1I1 (PubMed:10848625).
            Interacts with NCOA1 (By similarity). Interacts with NCOA3,
            SMARCA4, SMARCC1, SMARCD1, and SMARCE1 (By similarity). Interacts
            with CLOCK, CRY1 and CRY2 in a ligand-dependent fashion
            (PubMed:22170608, PubMed:28751364). Interacts with CIART
            (PubMed:24736997). Interacts with RWDD3 (By similarity). Interacts
            with UBE2I/UBC9 and this interaction is enhanced in the presence of
            RWDD3 (By similarity). Interacts with GRIP1 (By similarity).
            Interacts with NR4A3 (via nuclear receptor DNA-binding domain),
            represses transcription activity of NR4A3 on the POMC promoter Nur
            response element (NurRE) (By similarity). Directly interacts with
            PNRC2 to attract and form a complex with UPF1 and DCP1A; the
            interaction leads to rapid mRNA degradation (By similarity).
            Interacts with GSK3B (By similarity). Interacts with FNIP1 and
            FNIP2 (By similarity). Interacts (via C-terminus) with HNRNPU (via
            C-terminus) (By similarity). Interacts with MCM3AP (By similarity).
            Interacts (via domain NR LBD) with HSP90AA1 and HSP90AB1
            (PubMed:27686098). In the absence of hormonal ligand, interacts
            with TACC1 (By similarity). Interacts (via NR LBD domain) with
            ZNF764 (via KRAB domain); the interaction regulates transcription
            factor activity of NR3C1 by directing its actions toward certain
            biologic pathways (By similarity). {ECO:0000250|UniProtKB:P04150,
            ECO:0000250|UniProtKB:P06536, ECO:0000269|PubMed:10678832,
            ECO:0000269|PubMed:10848625, ECO:0000269|PubMed:11278753,
            ECO:0000269|PubMed:21994940, ECO:0000269|PubMed:22170608,
            ECO:0000269|PubMed:24736997, ECO:0000269|PubMed:27686098,
            ECO:0000269|PubMed:28751364, ECO:0000269|PubMed:9195923,
            ECO:0000269|PubMed:9528750, ECO:0000269|PubMed:9742105}.
            [INTERACTION] P06537; O88485: Dync1i1; NbExp=2; IntAct=EBI-492753,
            EBI-492834; P06537; P30416: Fkbp4; NbExp=3; IntAct=EBI-492753,
            EBI-492746; P06537; Q64378: Fkbp5; NbExp=2; IntAct=EBI-492753,
            EBI-492796; P06537; P11499: Hsp90ab1; NbExp=2; IntAct=EBI-492753,
            EBI-492813; P06537-1; P97784: Cry1; NbExp=3; IntAct=EBI-15959147,
            EBI-1266607; P06537-1; Q9R194: Cry2; NbExp=3; IntAct=EBI-15959147,
            EBI-1266619.
            [SUBCELLULAR LOCATION] Cytoplasm {ECO:0000269|PubMed:11278753,
            ECO:0000269|PubMed:25676786, ECO:0000269|PubMed:27686098}. Nucleus
            {ECO:0000269|PubMed:10678832, ECO:0000269|PubMed:11278753,
            ECO:0000269|PubMed:25676786, ECO:0000269|PubMed:27686098}.
            Note=Cytoplasmic in the absence of ligand, nuclear after
            ligand-binding (PubMed:11278753). The hormone-occupied receptor
            undergoes rapid exchange between chromatin and the nucleoplasmic
            compartment (PubMed:10678832). In the presence of NR1D1 shows a
            time-dependent subcellular localization, localizing to the
            cytoplasm at ZT8 and to the nucleus at ZT20 (PubMed:27686098).
            Lacks this diurnal pattern of localization in the absence of NR1D1,
            localizing to both nucleus and the cytoplasm at ZT8 and ZT20
            (PubMed:27686098). {ECO:0000269|PubMed:10678832,
            ECO:0000269|PubMed:11278753, ECO:0000269|PubMed:27686098}.
            [SUBCELLULAR LOCATION] [Isoform 1]: Cytoplasm
            {ECO:0000250|UniProtKB:P04150}. Nucleus
            {ECO:0000250|UniProtKB:P04150}. Mitochondrion
            {ECO:0000250|UniProtKB:P04150}. Cytoplasm, cytoskeleton, spindle
            {ECO:0000250|UniProtKB:P04150}. Cytoplasm, cytoskeleton,
            microtubule organizing center, centrosome
            {ECO:0000250|UniProtKB:P04150}. Note=After ligand activation,
            translocates from the cytoplasm to the nucleus.
            {ECO:0000250|UniProtKB:P04150}.
            [SUBCELLULAR LOCATION] [Isoform 3]: Nucleus
            {ECO:0000269|PubMed:20660300}. Cytoplasm
            {ECO:0000269|PubMed:20660300}. Note=Expressed predominantly in the
            nucleus with some expression also detected in the cytoplasm.
            {ECO:0000269|PubMed:20660300}.
            [ALTERNATIVE PRODUCTS] Event=Alternative splicing, Alternative
            initiation; Named isoforms=5; Name=1; Synonyms=1-A, GR form A,
            Alpha; IsoId=P06537-1; Sequence=Displayed; Name=2; Synonyms=2-A, GR
            form B, Gamma; IsoId=P06537-2; Sequence=VSP_003704; Name=1-B;
            IsoId=P06537-3; Sequence=VSP_018774; Name=2-B; IsoId=P06537-4;
            Sequence=VSP_018774, VSP_003704; Name=3; Synonyms=Beta;
            IsoId=P06537-5; Sequence=VSP_058320, VSP_058321.
            [TISSUE SPECIFICITY] Expressed in spleen, kidney and liver
            (PubMed:20660300). Expressed in a circadian manner in the liver
            (PubMed:27686098). {ECO:0000269|PubMed:20660300,
            ECO:0000269|PubMed:27686098}.
            [TISSUE SPECIFICITY] [Isoform 3]: Expressed at highest level in
            spleen with lesser amounts in kidney and liver.
            {ECO:0000269|PubMed:20660300}.
            [INDUCTION] [Isoform 1]: Down-regulated by glucocorticoids.
            {ECO:0000269|PubMed:20660300}.
            [INDUCTION] [Isoform 3]: Up-regulated by glucocorticoids and
            insulin. {ECO:0000269|PubMed:20660300}.
            [DOMAIN] Composed of three domains: a modulating N-terminal domain,
            a DNA-binding domain and a C-terminal ligand-binding domain. The
            ligand-binding domain is required for correct chromosome
            segregation during mitosis although ligand binding is not required.
            {ECO:0000250|UniProtKB:P04150}.
            [PTM] Acetylation by CLOCK reduces its binding to glucocorticoid
            response elements and its transcriptional activity.
            {ECO:0000250|UniProtKB:P04150}.
            [PTM] Increased proteasome-mediated degradation in response to
            glucocorticoids. {ECO:0000269|PubMed:11555652}.
            [PTM] Phosphorylated in the absence of hormone; becomes
            hyperphosphorylated in the presence of glucocorticoids.
            Phosphorylated in the absence of hormone; becomes
            hyperphosphorylated in the presence of glucocorticoid. The Ser-221,
            Ser-243 and Ser-421-phosphorylated forms are mainly cytoplasmic,
            and the Ser-229-phosphorylated form is nuclear (By similarity).
            Phosphorylation at Ser-229 increases transcriptional activity (By
            similarity). Phosphorylation at Ser-221, Ser-243 and Ser-421
            decreases signaling capacity (By similarity). Phosphorylation at
            Ser-421 may protect from glucocorticoid-induced apoptosis (By
            similarity). Phosphorylation at Ser-221 and Ser-229 is not required
            in regulation of chromosome segregation (By similarity). May be
            dephosphorylated by PPP5C, attenuates NR3C1 action
            (PubMed:21994940). {ECO:0000250|UniProtKB:P04150,
            ECO:0000269|PubMed:2019585, ECO:0000269|PubMed:21994940}.
            [PTM] Sumoylation at Lys-294 and Lys-310 negatively regulates its
            transcriptional activity. Sumoylation at Lys-718 positively
            regulates its transcriptional activity in the presence of RWDD3.
            Sumoylation at Lys-294 and Lys-310 is dispensable whereas
            sumoylation at Lys-718 is critical for the stimulatory effect of
            RWDD3 on its transcriptional activity. Heat shock increases
            sumoylation in a RWDD3-dependent manner.
            {ECO:0000250|UniProtKB:P06536}.
            [PTM] Ubiquitinated; restricts glucocorticoid-mediated
            transcriptional signaling. {ECO:0000269|PubMed:11555652}.
            [POLYMORPHISM] The poly-Gln region in 78-91 is polymorphic
            (PubMed:15489334, PubMed:16141072, PubMed:17012242,
            PubMed:20660300, PubMed:3780669). Polymorphism plays a role in
            complex mechanisms leading to lower corticosterone response to
            stress, and may also be associated with decreased locomotive and
            increased anxiety-type behaviors (PubMed:17012242).
            {ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:16141072,
            ECO:0000269|PubMed:17012242, ECO:0000269|PubMed:20660300,
            ECO:0000269|PubMed:3780669}.
            [MISCELLANEOUS] T-cell is a critical cellular target of GR, as
            immune activation in mice lacking GR resulted in significant
            mortality. This lethal activation is rescued by PTGS2 inhibition
            but not steroid administration or cytokine neutralization.
            [MISCELLANEOUS] [Isoform 2]: Produced by alternative splicing.
            {ECO:0000305}.
            [MISCELLANEOUS] [Isoform 1-B]: Produced by alternative initiation
            at Met-28 of isoform 1. {ECO:0000305}.
            [MISCELLANEOUS] [Isoform 2-B]: Produced by alternative initiation
            at Met-28 of isoform 2. {ECO:0000305}.
            [SIMILARITY] Belongs to the nuclear hormone receptor family. NR3
            subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..792
                     /organism="Mus musculus"
                     /db_xref="taxon:10090"
     gene            1..792
                     /gene="Nr3c1"
                     /gene_synonym="Grl"
                     /gene_synonym="Grl1"
     Protein         1..792
                     /product="Glucocorticoid receptor"
                     /note="GR; Nuclear receptor subfamily 3 group C member 1"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..792
                     /region_name="Mature chain"
                     /note="Glucocorticoid receptor. /id=PRO_0000019939."
     Region          1..436
                     /region_name="Region of interest in the sequence"
                     /note="Modulating."
     Region          1..27
                     /region_name="Splicing variant"
                     /note="Missing (in isoform 1-B and isoform 2-B).
                     /evidence=ECO:0000305. /id=VSP_018774."
     Region          1..25
                     /region_name="Region of interest in the sequence"
                     /note="Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite."
     Site            1
                     /site_type="mutagenized"
                     /note="M->T: Abolishes expression of A-type isoforms.
                     /evidence=ECO:0000269|PubMed:11435610."
     Site            24
                     /site_type="methylation"
                     /note="Omega-N-methylarginine.
                     /evidence=ECO:0007744|PubMed:24129315."
     Region          27..418
                     /region_name="GCR"
                     /note="Glucocorticoid receptor; pfam02155"
                     /db_xref="CDD:426625"
     Site            28
                     /site_type="mutagenized"
                     /note="M->T: Abolishes expression of B-type isoforms. 1-B.
                     /evidence=ECO:0000269|PubMed:11435610."
     Site            46
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0000250|UniProtKB:P04150."
     Region          67..98
                     /region_name="Region of interest in the sequence"
                     /note="Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite."
     Region          78..86
                     /region_name="Variant"
                     /note="Missing. /evidence=ECO:0000269|PubMed:15489334,
                     ECO:0000269|PubMed:16141072, ECO:0000269|PubMed:20660300,
                     ECO:0000269|PubMed:3780669."
     Region          91
                     /region_name="Variant"
                     /note="Missing. /evidence=ECO:0000269|PubMed:17012242."
     Site            131
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0000269|PubMed:2019585."
     Region          148..201
                     /region_name="Region of interest in the sequence"
                     /note="Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite."
     Site            152
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0000250|UniProtKB:P04150."
     Site            159
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0000269|PubMed:2019585."
     Site            168
                     /site_type="phosphorylation"
                     /note="Phosphothreonine.
                     /evidence=ECO:0000269|PubMed:2019585."
     Site            221
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0000269|PubMed:2019585,
                     ECO:0000269|PubMed:21994940."
     Site            229
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0000269|PubMed:2019585,
                     ECO:0000269|PubMed:21994940."
     Site            243
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0000269|PubMed:2019585,
                     ECO:0000269|PubMed:21994940."
     Site            284
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0000250|UniProtKB:P04150."
     Bond            bond(294)
                     /bond_type="xlink"
                     /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
                     G-Cter in SUMO); alternate.
                     /evidence=ECO:0000250|UniProtKB:P04150."
     Bond            bond(294)
                     /bond_type="xlink"
                     /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
                     G-Cter in SUMO2); alternate.
                     /evidence=ECO:0000250|UniProtKB:P04150."
     Bond            bond(310)
                     /bond_type="xlink"
                     /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
                     G-Cter in SUMO); alternate.
                     /evidence=ECO:0000250|UniProtKB:P04150."
     Bond            bond(310)
                     /bond_type="xlink"
                     /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
                     G-Cter in SUMO2); alternate.
                     /evidence=ECO:0000250|UniProtKB:P04150."
     Site            324
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0000269|PubMed:2019585."
     Site            421
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:21183079."
     Region          432
                     /region_name="Conflict"
                     /note="P -> L (in Ref. 4; BAE33674).
                     /evidence=ECO:0000305."
     Region          433..510
                     /region_name="NR_DBD_GR_PR"
                     /note="DNA-binding domain of glucocorticoid receptor (GR)
                     is composed of two C4-type zinc fingers; cd07172"
                     /db_xref="CDD:143546"
     Site            434..509
                     /site_type="DNA binding"
                     /note="Nuclear receptor.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00407."
     Bond            bond(435)
                     /bond_type="xlink"
                     /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
                     G-Cter in ubiquitin).
                     /evidence=ECO:0000305|PubMed:11555652."
     Site            435
                     /site_type="mutagenized"
                     /note="K->A: Abolishes glucocorticoid-mediated degradation
                     and enhances transcription trans-activation.
                     /evidence=ECO:0000269|PubMed:11555652."
     Site            order(437,440,454,457,473,479,489,492)
                     /site_type="other"
                     /note="zinc binding site [ion binding]"
                     /db_xref="CDD:143546"
     Region          437..457
                     /region_name="Zinc finger region"
                     /note="NR C4-type.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00407."
     Region          446
                     /region_name="Conflict"
                     /note="G -> V (in Ref. 1; CAA28031).
                     /evidence=ECO:0000305."
     Site            order(447..449,455..456,458..459,462..463,471,486..487,
                     493)
                     /site_type="DNA binding"
                     /note="DNA binding site [nucleotide binding]"
                     /db_xref="CDD:143546"
     Region          467
                     /region_name="Splicing variant"
                     /note="G -> GR (in isoform 2 and isoform 2-B).
                     /evidence=ECO:0000303|PubMed:2911477. /id=VSP_003704."
     Site            order(472..474,476,479..480,484..485,488)
                     /site_type="other"
                     /note="dimer interface [polypeptide binding]"
                     /db_xref="CDD:143546"
     Region          473..497
                     /region_name="Zinc finger region"
                     /note="NR C4-type.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00407."
     Site            493
                     /site_type="mutagenized"
                     /note="R->A: Abolishes transactivation activity.
                     /evidence=ECO:0000269|PubMed:25676786."
     Site            493
                     /site_type="mutagenized"
                     /note="R->C: Abolishes transcriptional activity. Does not
                     impair ligand binding.
                     /evidence=ECO:0000269|PubMed:25676786."
     Site            493
                     /site_type="mutagenized"
                     /note="R->K: Does not change transactivation activity.
                     /evidence=ECO:0000269|PubMed:25676786."
     Site            496
                     /site_type="acetylation"
                     /note="N6-acetyllysine.
                     /evidence=ECO:0000250|UniProtKB:P04150."
     Region          501..792
                     /region_name="Region of interest in the sequence"
                     /note="Interaction with CLOCK. /evidence=ECO:0000250."
     Region          503..538
                     /region_name="Region of interest in the sequence"
                     /note="Hinge."
     Site            508
                     /site_type="acetylation"
                     /note="N6-acetyllysine.
                     /evidence=ECO:0000250|UniProtKB:P04150."
     Site            510
                     /site_type="acetylation"
                     /note="N6-acetyllysine.
                     /evidence=ECO:0000250|UniProtKB:P04150."
     Site            511
                     /site_type="acetylation"
                     /note="N6-acetyllysine.
                     /evidence=ECO:0000250|UniProtKB:P04150."
     Region          539..773
                     /region_name="Domain"
                     /note="NR LBD.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01189."
     Region          546..792
                     /region_name="NR_LBD_GR"
                     /note="Ligand binding domain of the glucocorticoid
                     receptor, a member of the nuclear receptor superfamily;
                     cd07076"
                     /db_xref="CDD:132761"
     Region          547..712
                     /region_name="Region of interest in the sequence"
                     /note="Interaction with CRY1. /evidence=ECO:0000250."
     Region          547..554
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Site            order(560,562..566,629..630,640..641,643,645)
                     /site_type="other"
                     /note="dimer interface [polypeptide binding]"
                     /db_xref="CDD:132761"
     Region          571..594
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Site            order(575,578..579,582,585..586,615..616,619..620,623,626,
                     638,657,661,747,750,752)
                     /site_type="other"
                     /note="ligand binding site [chemical binding]"
                     /db_xref="CDD:132761"
     Site            order(590,594,600,604..605,607..608,611..612,767,770..771,
                     773..774,778)
                     /site_type="other"
                     /note="coactivator recognition site [polypeptide binding]"
                     /db_xref="CDD:132761"
     Region          599..601
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Region          604..631
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Region          634..639
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Region          642..644
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Region          646..649
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Region          652..654
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Region          655..671
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Region          675..686
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Region          688..691
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Region          698..717
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Bond            bond(718)
                     /bond_type="xlink"
                     /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
                     G-Cter in SUMO). /evidence=ECO:0000250|UniProtKB:P04150."
     Region          723..756
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Region          744..757
                     /region_name="Splicing variant"
                     /note="VENLLSYCFQTFLD -> STKHKSKTTAKKKK (in isoform 3).
                     /id=VSP_058320."
     Region          758..792
                     /region_name="Splicing variant"
                     /note="Missing (in isoform 3). /id=VSP_058321."
     Region          758..760
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Region          766..780
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Region          784..786
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3MNP."
     Region          792
                     /region_name="Conflict"
                     /note="K -> E (in Ref. 4; BAE33674).
                     /evidence=ECO:0000305."
ORIGIN      
        1 mdskeslapp grdevpssll grgrgsvmdl yktlrggatv kvsasspsva aasqadskqq
       61 rilldfskgs asnaqqqqqq qqqqqqqqqq qpqpdlskav slsmglymge tetkvmgndl
      121 gypqqgqlgl ssgetdfrll eesianlnrs tsrpenpkss tpaagcatpt ekefpqthsd
      181 psseqqnrks qpgtnggsvk lyttdqstfd ilqdlefsag spgketnesp wrsdlliden
      241 llsplagedd pfllegdvne dckplilpdt kpkiqdtgdt ilsspssval pqvktekddf
      301 ielctpgvik qeklgpvycq asfsgtniig nkmsaisvhg vstsggqmyh ydmntaslsq
      361 qqdqkpvfnv ippipvgsen wnrcqgsged nltslgamnf agrsvfsngy sspgmrpdvs
      421 sppsssstat gpppklclvc sdeasgchyg vltcgsckvf fkravegqhn ylcagrndci
      481 idkirrkncp acryrkclqa gmnlearktk kkikgiqqat agvsqdtsen anktivpaal
      541 pqltptlvsl leviepevly agydssvpds awrimttlnm lggrqviaav kwakaipgfr
      601 nlhlddqmtl lqyswmflma falgwrsyrq asgnllcfap dliineqrmt lpcmydqckh
      661 mlfistelqr lqvsyeeylc mktllllssv pkeglksqel fdeirmtyik elgkaivkre
      721 gnssqnwqrf yqltklldsm hdvvenllsy cfqtfldksm siefpemlae iitnqipkys
      781 ngnikkllfh qk
//

